JP2024530244A5 - - Google Patents

Info

Publication number
JP2024530244A5
JP2024530244A5 JP2024509421A JP2024509421A JP2024530244A5 JP 2024530244 A5 JP2024530244 A5 JP 2024530244A5 JP 2024509421 A JP2024509421 A JP 2024509421A JP 2024509421 A JP2024509421 A JP 2024509421A JP 2024530244 A5 JP2024530244 A5 JP 2024530244A5
Authority
JP
Japan
Prior art keywords
approximately
cyclosporine
weight
formulation
nanomicelle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024509421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530244A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/059176 external-priority patent/WO2021224901A2/en
Publication of JP2024530244A publication Critical patent/JP2024530244A/ja
Publication of JP2024530244A5 publication Critical patent/JP2024530244A5/ja
Pending legal-status Critical Current

Links

JP2024509421A 2021-08-20 2021-10-06 安定なシクロスポリン眼科用製剤及びその製造プロセス Pending JP2024530244A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202121037917 2021-08-20
IN202121037917 2021-08-20
PCT/IB2021/059176 WO2021224901A2 (en) 2021-08-20 2021-10-06 Stable cyclosporine ophthalmic formulation and manufacturing process thereof

Publications (2)

Publication Number Publication Date
JP2024530244A JP2024530244A (ja) 2024-08-16
JP2024530244A5 true JP2024530244A5 (https=) 2024-10-16

Family

ID=78468801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024509421A Pending JP2024530244A (ja) 2021-08-20 2021-10-06 安定なシクロスポリン眼科用製剤及びその製造プロセス
JP2024509422A Pending JP2024530245A (ja) 2021-08-20 2022-08-22 安定なシクロスポリン眼科用製剤及びその製造プロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024509422A Pending JP2024530245A (ja) 2021-08-20 2022-08-22 安定なシクロスポリン眼科用製剤及びその製造プロセス

Country Status (8)

Country Link
US (2) US20240342086A1 (https=)
EP (2) EP4387589A4 (https=)
JP (2) JP2024530244A (https=)
CN (2) CN117957011A (https=)
AU (2) AU2021267217A1 (https=)
IL (2) IL310823A (https=)
MX (2) MX2024002234A (https=)
WO (2) WO2021224901A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4719350A1 (en) * 2023-05-29 2026-04-08 Sun Pharmaceutical Industries Limited Stable cyclosporine ophthalmic formulation and manufacturing process thereof
WO2025163677A1 (en) * 2024-01-31 2025-08-07 Registrar, Panjab University, Chandigarh Nanomicellar composition for high permeation and extended-release drug delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY180581A (en) * 2011-05-27 2020-12-02 Allergan Inc A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
HK1211867A1 (en) * 2012-08-24 2016-06-03 Sun Pharma Global Fze Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
US20200237859A1 (en) * 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
WO2017083167A1 (en) * 2015-11-10 2017-05-18 Ocular Technologies Sarl Topical formulations and uses thereof
RU2747455C2 (ru) * 2016-02-29 2021-05-05 Сан Фарма Глобал Фзе Циклоспорин-содержащие лекарственные формы для наружного применения и их применения

Similar Documents

Publication Publication Date Title
JP2024530244A5 (https=)
CN101596163B (zh) 阿咖酚微丸制剂及其制备方法
AU2012214939B2 (en) Sildenafil-free base-containing film preparation and method for producing same
JP2006500377A5 (https=)
US20200046662A1 (en) Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
US9603797B2 (en) Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same
JP2024530245A5 (https=)
IL310887A (en) Stable cyclosporine ophthalmic formulation and its manufacturing process
RU2011130508A (ru) Рецептура для перорального трансмукозального применения гиполипидемических лекарственных средств
JP2006517236A (ja) 急速分散性医薬固形剤形における食用酸の使用
CN106109426A (zh) 一种双氯芬酸钠肠溶片及其制备方法
JP5500162B2 (ja) 点眼剤
CN111358758A (zh) 一种盐酸溴己新分散片及其制备方法
JP2004059479A (ja) 点眼剤組成物
JP2002284673A (ja) 生理学的に許容可能な水溶液の調製法およびこの方法により得られた溶液
US10517837B2 (en) Process for obtaining a system for the controlled delivery of a biologically active substance and controlled delivery system obtained thereby
CN116850140A (zh) 一种注射用氨苄西林钠舒巴坦钠药物组合物及其制备方法
CN111803464A (zh) 一种塞来昔布胶囊制剂
AU2006218043B2 (en) Aqueous topical gel of high stability based on metronidazole and method of preparation
JP4961671B2 (ja) 点眼剤
JPH02164829A (ja) ヒアルロン酸点眼液
RU2535035C1 (ru) Способ получения стерильной саможелирующейся альгинатной системы
NO781688L (no) Fremgangsmaate ved fremstilling av farmakologisk aktive midler
WO2024186829A2 (en) Orally disintegrating tablet and methods of making thereof
CN105232466B (zh) 一种用于重金属离子吸附的纳米颗粒的制备方法